Topical treatment before Mohs can reduce recurrence of extramammary Paget's

03/27/2012 | SkinAndAllergyNews.com

Applying topical 5% imiquimod or 5-fluorouracil prior to Mohs surgery or ablation for extramammary Paget's disease helps identify all of the active foci and can reduce the risk of recurrence, says Dr. Theodore Rosen, a professor of dermatology at Baylor College of Medicine. Imiquimod as primary therapy has a 22% failure rate, and wide surgical excision alone has a recurrence rate of up to 54%, studies show. Some research suggests that cytokeratin staining can help determine whether patients also have an internal malignancy.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN